Barchart on Facebook
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Mallinckrodt Plc (MNK)

Mallinckrodt Plc (MNK)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 63,442
  • Shares Outstanding, K 84,589
  • Annual Sales, $ 3,163 M
  • Annual Income, $ -996,500 K
  • 60-Month Beta 3.06
  • Price/Sales 0.03
  • Price/Cash Flow 0.05
  • Price/Book 0.07
Trade MNK with:
  • Price/Earnings ttm 0.14
  • Earnings Per Share ttm 8.00
  • Most Recent Earnings 1.89 on 08/04/20
  • Next Earnings Date 11/03/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Sell
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate 1.38
  • Number of Estimates 7
  • High Estimate 1.61
  • Low Estimate 1.17
  • Prior Year 2.07
  • Growth Rate Est. (year over year) -33.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.7500 unch
on 10/09/20
1.4800 -49.32%
on 09/18/20
-0.6600 (-46.81%)
since 09/09/20
3-Month
0.7500 unch
on 10/09/20
3.1999 -76.56%
on 07/16/20
-1.5900 (-67.95%)
since 07/09/20
52-Week
0.7500 unch
on 10/09/20
6.4200 -88.32%
on 01/21/20
-1.5300 (-67.11%)
since 10/09/19

Most Recent Stories

More News
Avenue Therapeutics' Pain Drug Gets Complete Response Letter

Avenue Therapeutics' (ATXI) NDA seeking an approval for its pipeline candidate tramadol to treat postoperative pain gets a CRL from the FDA, based on potential safety concerns. Shares down.

ENDP : 5.64 (+13.25%)
JNJ : 144.32 (-2.55%)
MNK : 0.7500 (-31.19%)
ATXI : 3.79 (-1.30%)
Mallinckrodt Secures Broad Consensus with Key Stakeholders on Comprehensive Chapter 11 Restructuring

, /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK) ("" or the "Company") today announced that it has voluntarily initiated Chapter 11 proceedings in the U.S. Bankruptcy Court for the District of Delaware to...

MNK : 0.7500 (-31.19%)
Mallinckrodt Gets CRL From FDA for Terlipressin, Shares Fall

Mallinckrodt (MNK) gets a Complete Response Letter from the FDA for its NDA seeking approval for terlipressin to treat adults with hepatorenal syndrome type 1.

EBS : 95.97 (-2.94%)
ALIM : 4.61 (-1.28%)
TECH : 264.58 (-0.41%)
MNK : 0.7500 (-31.19%)
Mallinckrodt Receives a Complete Response Letter from the U.S. Food and Drug Administration (FDA) for Terlipressin for the Treatment of Hepatorenal Syndrome Type 1 (HRS-1)

, /PRNewswire/ --  (NYSE: MNK), a global biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding the company's...

MNK : 0.7500 (-31.19%)
Why Is Mallinckrodt (MNK) Down 3.9% Since Last Earnings Report?

Mallinckrodt (MNK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

MNK : 0.7500 (-31.19%)
Implied Volatility Surging for Mallinckrodt (MNK) Stock Options

Investors need to pay close attention to Mallinckrodt (MNK) stock based on the movements in the options market lately.

MNK : 0.7500 (-31.19%)
Mallinckrodt Announces 2020 Investigator Award to Further Advances in ECP Immunomodulation

-- EUR50,000 award goes to University Hospital of Lille in France to fund research into the potential impact of Extracorporeal Photopheresis (ECP) on fibrosing processes --

MNK : 0.7500 (-31.19%)
Global Brain Tumor Therapeutics Market Targeted to Reach $3.4 Billion by 2025

, /PRNewswire/ -- Across the globe, there has been an increasing prevalence on brain cancer over the past few years and the industry is expected to grow as a result. The major driving factor responsible...

CNSP : 1.8200 (-0.55%)
MNK : 0.7500 (-31.19%)
AMRN : 5.03 (-2.33%)
MRK : 78.67 (-1.45%)
IMUX : 19.60 (+2.56%)
Mallinckrodt's Hobart, N.Y. Site Recognized With Two Manufacturing Leadership Awards

, /PRNewswire/ --  (NYSE: MNK), a global biopharmaceutical company, today announced that its Specialty Generics business has been recognized as a Manufacturing Leadership Award winner for outstanding...

MNK : 0.7500 (-31.19%)
Opioid Crisis Deepens as Teva, Allergan Face Fraud Charges

The DFS charges claim that Teva (TEVA) and Allergan (AGN) used fraudulent marketing and promotional campaigns to promote their opioid products

JNJ : 144.32 (-2.55%)
TEVA : 9.29 (-1.28%)
ABBV : 84.31 (-2.27%)
MNK : 0.7500 (-31.19%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Mallinckrodt Plc. is engaged in pharmaceuticals business. It develops, manufactures, markets and distributes specialty pharmaceutical products and medical imaging agents. The company's Specialty Pharmaceuticals segment includes branded and generic drugs and Medical Imaging segment includes contrast media...

See More

Key Turning Points

2nd Resistance Point 1.0833
1st Resistance Point 0.9167
Last Price 0.7500
1st Support Level 0.6667
2nd Support Level 0.5833

See More

52-Week High 6.4200
Fibonacci 61.8% 4.2541
Fibonacci 50% 3.5850
Fibonacci 38.2% 2.9159
Last Price 0.7500
52-Week Low 0.7500

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar